Methionine

Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical Homocystinuria

Retrieved on: 
Friday, February 2, 2024

CAMBRIDGE, Mass., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, announced today the publication of a manuscript detailing the development and activity of SYNB1353 in preclinical models and demonstrating safety, tolerability, and clinical proof of mechanism in healthy volunteers through the successful lowering of methionine (Met), a precursor to homocysteine, in a dietary model of classical homocystinuria (HCU).

Key Points: 
  • Among findings outlined in the manuscript, SYNB1353 efficiently degraded both dietary and entero-recirculating methionine to prevent its absorption and subsequent conversion to homocysteine in preclinical models, suggesting that SYNB1353 should result in lowering of plasma homocysteine levels in HCU patients.
  • In addition, in results from the clinical study in healthy volunteers, SYNB1353 was generally well-tolerated and adverse events were mild to moderate, transient, and predominantly gastrointestinal in nature.
  • The proportion of subjects reporting gastrointestinal events were similar for the SYNB1353 and placebo cohorts (36.4% and 37.5%, respectively).
  • “Importantly, the SYNB1353 program has built on learnings and progress from our other rare metabolic disease programs, including the design of the potential therapeutic, the preclinical research and the advancement in clinical development.”
    The publication, entitled “The Live Biotherapeutic SYNB1353 Decreases Plasma Methionine via Directed Degradation in Animal Models and Healthy Volunteers,” and published in the peer-reviewed journal, Cell Host & Microbe, is now available online at https://www.sciencedirect.com/science/article/pii/S193131282400009X .

Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Retrieved on: 
Thursday, November 9, 2023

CAMBRIDGE, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non-systemically absorbed biotherapeutics to transform the care of serious diseases, today reported financial results for the third quarter ended September 30, 2023, and provided a corporate update.

Key Points: 
  • Publication of Synpheny-1 Phase 2 study results for the PKU program in the journal Nature Metabolism.
  • Presentation of Synpheny-1 Phase 2 study results by lead investigator Dr. Jerry Vockley of the University of Pittsburgh at the 37th E.S.PKU Conference 2023.
  • Revenue for the three months ended September 30, 2023 was $0.4 million compared to $0.7 million for the corresponding period in 2022.
  • General and administrative expenses were $3.4 million for the three months ended September 30, 2023, compared to $4.4 million for the corresponding period in 2022.

The Fanion™ Kitchen Gadget Offers Relief From Irritating Onion-Cutting, Slicing, and Dicing Tears During Food Prep

Retrieved on: 
Wednesday, November 1, 2023

ATLANTA, Nov. 1, 2023 /PRNewswire-PRWeb/ -- Fanion, a small family business dedicated to innovations in kitchen gadgetry, has announced the official launch of their first product, The Fanion™ is a convenient, battery-powered kitchen fan that eliminates painful tears when chopping, cutting, slicing, and dicing onions and other eye-irritating vegetables like shallots and peppers by dispersing those devastating fumes away from our sensitive eyes. This cute kitchen direct-to-consumer product is now being sold on MyFanion.com for $29.95 and can be shipped anywhere in the continental U.S.

Key Points: 
  • I tried EVERYTHING – including all of those viral 'hacks' you see on Instagram and TikTok to stop those onion tears.
  • Glenn Smith, Founder, The Fanion™
    "Nobody wants to cry in the kitchen during food prep, which is a time for family bonding in our household," said Glenn Smith, the Founder of The Fanion™ .
  • I tried EVERYTHING – including all of those viral 'hacks' you see on Instagram and TikTok to stop those onion tears.
  • Order in early November and The Fanion™ can be a part of your Thanksgiving meal prep.

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Unveil Wide Range of Innovative Radiation Oncology Research at the 2023 ASTRO Annual Meeting

Retrieved on: 
Friday, September 29, 2023

NEW BRUNSWICK, N.J., Sept. 29, 2023 /PRNewswire/ -- Physician-scientists from Rutgers Cancer Institute of New Jersey and RWJBarnabas Health will present new, novel, and expansive radiation oncology data from their clinical research program at the 2023 American Society for Radiation Oncology (ASTRO) Annual Meeting, to be held in San Diego from October 1-4.  A total of 10 abstracts have been accepted, comprising clinical data and analyses that advance the understanding and use of radiation therapy in the treatment of lung, breast, pancreatic, and other cancers. Rutgers Cancer Institute and RWJBarnabas Health is New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center and the leading cancer program in the state.

Key Points: 
  • Rutgers Cancer Institute and RWJBarnabas Health is New Jersey's only National Cancer Institute-designated Comprehensive Cancer Center and the leading cancer program in the state.
  • "We are excited that the physician-scientists from our health system will be presenting significant and valuable information to advance the use of radiotherapy in cancer treatment at this year's ASTRO meeting," said Bruce Haffty, MD, MS, Chair, Radiation Oncology, Associate Vice Chancellor for Cancer Programs at Rutgers Cancer Institute of New Jersey, and System Director of Radiation Oncology at RWJBarnabas Health.
  • Highlights of accepted abstracts include the following:
    Findings of an analysis to explore genetic changes in aggressive pancreatic cancer.
  • The full list of presentations at this year's ASTRO Annual Meeting follows:

Hemp, Inc. Reports: Growing Legalization of Industrial Hemp Driving Global Demand for Hemp

Retrieved on: 
Thursday, September 28, 2023

LAS VEGAS, NV, Sept. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hemp, Inc. (OTC PINK: HEMP) is perfectly positioned at the forefront of the industrial hemp industry as demand increases and opportunities abound.

Key Points: 
  • LAS VEGAS, NV, Sept. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Hemp, Inc. (OTC PINK: HEMP) is perfectly positioned at the forefront of the industrial hemp industry as demand increases and opportunities abound.
  • The recent release of a comprehensive research report, Global Industrial Hemp Market (2023-2031) , says the global industrial hemp market is forecast to grow to $134.6 billion by 2030.
  • As one of the most rapidly growing plants on the planet, hemp is used to make a variety of products.
  • With the “growing legalization of industrial hemp farming around the world, the demand for industrial hemp has been exponential.

ZXCHEM USA presents Revolutionary New Manufacturing Process for Plant Proteins in the US and Canadian Markets

Retrieved on: 
Wednesday, September 6, 2023

We are excited to offer them in the US and Canadian markets for the first time," says Wade Zheng, President of ZXCHEM USA.

Key Points: 
  • We are excited to offer them in the US and Canadian markets for the first time," says Wade Zheng, President of ZXCHEM USA.
  • HydroRice™ PA80 is 100% rice protein while HydroPR™ 80 is a 40/60 blend of rice and pea protein.
  • Both products are manufactured with a revolutionary new process that does not use enzymes or hydrolyzation to change the protein functionality.
  • Anhui Shunxin has assigned ZXCHEM USA as the exclusive distributor for the US and Canadian markets.

The Pea Protein Market size to grow at a CAGR of 12.24% from 2022 to 2027; The high nutrient profile of pea protein and the rapid expansion of products boost market growth- Technavio

Retrieved on: 
Monday, August 14, 2023

The high nutrient profile of pea protein and the rapid expansion of products is a key factor driving the market growth.

Key Points: 
  • The high nutrient profile of pea protein and the rapid expansion of products is a key factor driving the market growth.
  • Pea protein is considered the third largest segment in terms of revenue in the vegetable protein market, which is ranked behind soy protein and wheat protein.
  • Hence, the high nutrient profile is expected to drive the pea protein market growth during the forecast period.
  • Hence, the rising demand for hydrolyzed pea protein is expected to drive the pea protein market growth during the forecast period.

Your genetic code has lots of 'words' for the same thing – information theory may help explain the redundancies

Retrieved on: 
Thursday, July 27, 2023

The universality of the genetic code indicates a common ancestry among all living organisms and the essential role this code plays in the structure, function and regulation of biological cells.

Key Points: 
  • The universality of the genetic code indicates a common ancestry among all living organisms and the essential role this code plays in the structure, function and regulation of biological cells.
  • Understanding how the genetic code works is the foundation of genetic engineering and synthetic biology.
  • Just as computers need strings of binary code to function, biological processes also rely on bits of information.

Different words for the same thing

    • Ribosomes read three-letter words called codons, and there are 64 different possible combinations of the four letters that make different codons.
    • In this list of 64 words, 61 encode amino acids, and three signal the ribosome to stop protein synthesis in the cell.
    • In fact, since there are only 20 amino acids but 61 different words to encode them, there is quite a lot of overlap.

Engineering nature’s guidelines

    • The mapping of the 61 codes onto the the 20 amino acids would be roughly equal, with each amino acid assigned three codons.
    • Not only does the final form of a protein need to be optimal, but so do its intermediate forms.
    • Scientists understand some of the guidelines that nature follows when engineering the genetic code.

Information theory and genetics

    • Nature’s affinity for optimization using this irrational number is responsible for the infinitely repeating fractals seen in jagged shorelines, fern leaves, snowflakes and trees.
    • Beyond biology, information optimization using e also has applications in mathematics and cosmology.
    • Entropy is a measure of disorder in a system, and the maximum entropy principle states that systems evolve to states of greater disorder.
    • Although there are many biological mysteries that scientists have yet to solve, information theory can be a powerful tool to help crack the genetic code.

Hydrogen Market worth $410.6 billion by 2030 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, July 26, 2023

Based on sector, the Hydrogen Market has been segmented into generation type, storage, and transportation.

Key Points: 
  • Based on sector, the Hydrogen Market has been segmented into generation type, storage, and transportation.
  • Since it generates no carbon dioxide when used, green hydrogen generation offers a workable answer to the problem of decarbonization.
  • This report segments the Hydrogen Market based on application into three segments: energy, mobility, and chemical & refinery.
  • Air Products will deploy a mobile hydrogen refueler at the airport to deliver hydrogen for the Toyota Mirai hydrogen fuel cell vehicle fleet.

Hydrogen Market worth $410.6 billion by 2030 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, July 26, 2023

Based on sector, the Hydrogen Market has been segmented into generation type, storage, and transportation.

Key Points: 
  • Based on sector, the Hydrogen Market has been segmented into generation type, storage, and transportation.
  • Since it generates no carbon dioxide when used, green hydrogen generation offers a workable answer to the problem of decarbonization.
  • This report segments the Hydrogen Market based on application into three segments: energy, mobility, and chemical & refinery.
  • Air Products will deploy a mobile hydrogen refueler at the airport to deliver hydrogen for the Toyota Mirai hydrogen fuel cell vehicle fleet.